AI formula readiness — every check, before first batch.
V5 evaluates a new or revised formula against materials, allergens, shelf-life, regulatory eligibility per market and cost impact — flagging blockers before the first pilot batch, not after the campaign is loaded.
What breaks without this.
New formulas hit production with hidden blockers
A restricted ingredient, an allergen conflict, a market where the SKU can't ship — discovered after batching starts.
R&D and RA operate on different data
R&D checks INCI, RA checks compliance, purchasing checks availability. The gaps between them are where launches slip.
Cost impact is a post-hoc surprise
Formula approved, then finance runs the numbers, then reformulation starts.
Records-by-execution. Compliance, by design.
Materials, availability and shelf-life
Every ingredient checked against approved supplier list, on-hand, on-order and expiry runway.
Allergen and cross-contamination
Allergen matrix checked against target line's prior campaign — cross-contact flagged.
Regulatory eligibility per market
INCI / IFRA / MoCRA / EU Cosmetics / FDA CFR / Health Canada NHP / SFDA — per market of intended sale.
Cost impact modelled
Standard-cost and margin impact modelled at the formula version — not at close.
One-click readiness report
Green / amber / red readiness report signed by R&D, RA and Ops before the formula is released to production.
What to look for when you're buying.
Readiness tools succeed when they see materials, allergens, regulations and cost in one check. Criteria to test.
Materials, availability, shelf-life
What it tests: Does the check see ASL, on-hand, on-order, expiry?
Why it matters: R&D-only checks miss supply reality.
V5: All four.
Allergen cross-contact
What it tests: Is the check against the target line's prior campaign?
Why it matters: Line-specific cross-contact is the real risk.
V5: Target-line aware.
Regulatory per market
What it tests: Is eligibility checked per market of intended sale?
Why it matters: Multi-market launches fail on the market nobody checked.
V5: Per-market ruleset.
Cost modelling
What it tests: Is standard-cost and margin modelled at formula version?
Why it matters: Cost surprises after approval trigger reformulation.
V5: Modelled at version.
Green / amber / red output
What it tests: Is the output actionable, not a wall of data?
Why it matters: Data walls invite skipping.
V5: Traffic-light output with drill-down.
Signed handoff
What it tests: Is the readiness report a signed record?
Why it matters: Handoffs without evidence break.
V5: R&D / RA / Ops signed handoff.
Spreadsheet vs legacy QMS vs V5.
AI readiness vs a PLM tool and vs siloed checks.
| Capability | Spreadsheet | Legacy QMS | V5 Ultimate |
|---|---|---|---|
| Materials + supply | R&D-only | Sometimes | Full |
| Allergen line-aware | Rare | Rare | Native |
| Reg per market | Manual | Sometimes | Native |
| Cost modelled | Separate | Sometimes | At version |
| Signed handoff | Sometimes | Signed record |
The clauses, verbatim — and how V5 answers each.
Formula readiness touches every regulated market's product-content clauses.
Modernization of Cosmetics Regulation Act of 2022.
V5: MoCRA facility, product-listing and label-content requirements checked at readiness.
Cosmetic products regulation.
V5: INCI, prohibited/restricted substances and CPNP requirements checked.
Fragrance ingredient restrictions.
V5: IFRA restrictions applied per product category.
Preventive controls for human food.
V5: Food formula readiness includes preventive-controls check.
Step by step on the floor.
Readiness goes live in weeks.
- 1Setup
Rulesets subscribed
Customer content subscriptions (IFRA, Chemwatch, etc.) wired.
- 2Week 1
Markets defined
Per-SKU intended-market list captured on item master.
- 3Week 2
Readiness live
R&D can run readiness on any formula version.
- 4Ongoing
Signed handoff
Signed readiness becomes the R&D → Ops handoff record.
The math, with the assumptions visible.
ROI is measured in prevented launch slips and reformulation cycles.
Reformulations after approval
Cost and reg blockers caught before approval.
Launch slip driven by readiness surprise
Blockers surface at readiness, not at pilot.
Cross-functional meeting load on launch
Readiness report replaces the round-table.
One prevented late-stage reformulation typically pays the module.
What changed on the floor.
Setting
A skincare brand launching 20+ SKUs per year across US, EU, UK and Japan.
Before
Reformulations after approval were routine; launches slipped by weeks on markets nobody had checked in time.
After
One year on V5, reformulations-after-approval down materially; on-time launch rate up; RA team reallocated a headcount to registrations.
Proof points
- Every ingredient checked against ASL, stock and shelf-life
- Regulatory per market of intended sale
- Cross-contact allergen check against the target line
- Cost impact modelled at formula version
Built to satisfy
- MoCRA (US cosmetics)
- EU 1223/2009 (cosmetic products regulation)
- IFRA Code of Practice (fragrances)
- 21 CFR 117 (preventive controls — food)
- FSMA 204 (traceability requirements)
Related on V5
Frequently asked questions
Does this replace our regulatory content provider?+
No — V5 consumes your subscription (Chemwatch, IFRA, others) and applies it. The check is V5; the ruleset is your subscribed content.
Can we run it on a formula not yet approved?+
Yes — readiness is designed for the R&D-to-Ops handoff, not the post-approval check.
How is the market list defined?+
From the intended-market list on the item master. New markets can be added and re-checked in seconds.
See V5 on your own line.
Free trial, no card. Live in 7 days with guided onboarding.